Lore Decoster

6PUBLICATIONS

16CO-AUTHORS

Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Jul 06, 2026

Afatinib for Advanced Cancers Carrying an EGFR, HER2, or HER3 Mutation: An Open-Label, Phase II, Belgian Precision Study.

|May 27, 2021

Targeted Therapies in Older Adults With Solid Tumors.

Nicolò Matteo Luca Battisti, Lore Decoster, Grant R Williams

|Mar 12, 2021

Real-World Treatment Patterns, Epidermal Growth Factor Receptor (EGFR) Testing and Outcomes in EGFR-Mutated Advanced Non-small Cell Lung Cancer Patients in Belgium: Results from the REVEAL Study.

Kristof Cuppens, Liesbet Lodewyckx, Ingel Demedts

|May 11, 2019

Retrospective comparison of two consecutive cohorts of adjuvant chemotherapy regimens of cyclophosphamide with either docetaxel or paclitaxel in older patients with early breast cancer.

Sofie Joris, Christel Fontaine, Lore Decoster

|Dec 30, 2017

Docetaxel/cyclophosphamide chemotherapy in older patients with breast cancer.

Lore Decoster, Christel Fontaine, Leen Vanacker

|Jun 22, 2017

Geriatric Assessment and Functional Decline in Older Patients with Lung Cancer.

L Decoster, C Kenis, D Schallier

Pageof 1

Frequent Collaborators

Sofie Joris

Kristof Cuppens

Liesbet Lodewyckx

Ingel Demedts

Benoît Colinet

Koen Deschepper

Annelies Janssens

Daniella Galdermans

Thierry Pieters

Nicolò Matteo Luca Battisti

Frequent Collaborators

Sofie Joris

Kristof Cuppens

Liesbet Lodewyckx

Ingel Demedts